Mody Vino C, Kakar Manoj, Elfving Ase, Löfgren Stefan
St Erik's Eye Hospital, Karolinska Institute, Stockholm, Sweden.
Acta Ophthalmol. 2008 Mar;86(2):188-95. doi: 10.1111/j.1600-0420.2007.01022.x. Epub 2007 Oct 18.
To study if ascorbate supplementation decreases ultraviolet radiation (UVR)-induced cataract development in the guinea pig.
Sixty 6-9-week-old pigmented guinea pigs received drinking water supplemented with or without 5.5 mm l-ascorbate for 4 weeks. After supplementation, 40 animals were exposed unilaterally in vivo under anaesthesia to 80 kJ/m(2) UVR-B. One day later, the animals were killed and lenses were extracted. Degree of cataract was quantified by measurement of intensity of forward lens light scattering. Lens ascorbate concentration was determined with high-performance liquid chromatography (HPLC) with UVR detection at 254 nm. Twenty animals were used as non-exposed control.
Supplementation increased lens ascorbate concentration significantly. In UVR-exposed animals, mean 95% confidence intervals (CIs) for animal-averaged lens ascorbate concentration (micromol/g wet weight lens) were 0.54 +/- 0.07 (no ascorbate) and 0.83 +/- 0.05 (5.5 mm ascorbate). In non-exposed control animals, mean 95% CIs for animal-averaged lens ascorbate concentration (micromol/g wet weight lens) were 0.72 +/- 0.12 (0 mm ascorbate) and 0.90 +/- 0.15 (5.5 mm ascorbate). All non-exposed lenses were devoid of cataract. Superficial anterior cataract developed in all UVR-exposed lenses. The lens light scattering was 39.2 +/- 14.1 milli transformed equivalent diazepam concentration (m(tEDC)) without and 35.9 +/- 14.0 m(tEDC) with ascorbate supplementation.
Superficial anterior cataract develops in lenses exposed to UVR-B. Ascorbate supplementation is non-toxic to both UVR-B-exposed lenses and non-exposed control lenses. Ascorbate supplementation does not reduce in vivo lens forward light scattering secondary to UVR-B exposure in the guinea pig.
研究补充抗坏血酸是否能减少紫外线辐射(UVR)诱导的豚鼠白内障形成。
60只6 - 9周龄的有色豚鼠饮用添加或不添加5.5 mmol/L L-抗坏血酸的水,持续4周。补充后,40只动物在麻醉下单侧进行体内80 kJ/m(2)的UVR - B照射。一天后,处死动物并取出晶状体。通过测量晶状体前向光散射强度来量化白内障程度。用高效液相色谱法(HPLC)在254 nm处检测UVR来测定晶状体抗坏血酸浓度。20只动物作为未照射对照组。
补充显著提高了晶状体抗坏血酸浓度。在接受UVR照射的动物中,动物平均晶状体抗坏血酸浓度(微摩尔/克湿重晶状体)的平均95%置信区间(CI)分别为0.54±0.07(未补充抗坏血酸)和0.83±0.05(5.5 mmol/L抗坏血酸)。在未照射的对照动物中,动物平均晶状体抗坏血酸浓度(微摩尔/克湿重晶状体)的平均95% CI分别为0.72±0.12(0 mmol/L抗坏血酸)和0.90±0.15(5.5 mmol/L抗坏血酸)。所有未照射的晶状体均无白内障。所有接受UVR照射的晶状体均出现浅层前囊下白内障。未补充抗坏血酸时晶状体光散射为39.2±14.1毫转化等效地西泮浓度(m(tEDC)),补充抗坏血酸后为35.9±14.0 m(tEDC)。
暴露于UVR - B的晶状体出现浅层前囊下白内障。补充抗坏血酸对接受UVR - B照射的晶状体和未照射的对照晶状体均无毒。补充抗坏血酸不能减少豚鼠体内UVR - B照射引起的晶状体前向光散射。